Evidence map›Paper›PMID 38114733›Full record

ArticleScientific reports2023

Investigation of perfusion impairment in degenerative cervical myelopathy beyond the site of cord compression.

Anna Lebret, Simon Lévy, Nikolai Pfender, Mazda Farshad, Franziska C S Altorfer, Virginie Callot, Armin Curt, Patrick Freund, Maryam Seif

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 5 countries.

Anna LebretSpinal Cord Injury Center, Balgrist University Hospital, Zürich, Switzerland.
Simon LévyCNRS, CRMBM, Aix-Marseille University, Marseille, France.
Nikolai PfenderSpinal Cord Injury Center, Balgrist University Hospital, Zürich, Switzerland.
Mazda FarshadDepartment of Orthopedic Surgery, Balgrist University Hospital, Zürich, Switzerland.
Franziska C S AltorferDepartment of Orthopedic Surgery, Balgrist University Hospital, Zürich, Switzerland.
Virginie CallotCNRS, CRMBM, Aix-Marseille University, Marseille, France.
Armin CurtSpinal Cord Injury Center, Balgrist University Hospital, Zürich, Switzerland.
Patrick FreundSpinal Cord Injury Center, Balgrist University Hospital, Zürich, Switzerland.
Maryam SeifSpinal Cord Injury Center, Balgrist University Hospital, Zürich, Switzerland. maryam.seif@balgrist.ch.
Universitätsklinik Balgrist · CHAix-Marseille Université · FRMax Planck Institute for Human Cognitive and Brain Sciences · DE

Funding

International Foundation for Research in Paraplegia IRP-158Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung Eccellenza fellowship/181362Wings for Life WFL-CH-19/20
6 · The paper itself

Abstract

The aim of this study was to determine tissue-specific blood perfusion impairment of the cervical cord above the compression site in patients with degenerative cervical myelopathy (DCM) using intravoxel incoherent motion (IVIM) imaging. A quantitative MRI protocol, including structural and IVIM imaging, was conducted in healthy controls and patients. In patients, T2-weighted scans were acquired to quantify intramedullary signal changes, the maximal canal compromise, and the maximal cord compression. T2*-weighted MRI and IVIM were applied in all participants in the cervical cord (covering C1-C3 levels) to determine white matter (WM) and grey matter (GM) cross-sectional areas (as a marker of atrophy), and tissue-specific perfusion indices, respectively. IVIM imaging resulted in microvascular volume fraction ([Formula: see text]), blood velocity ([Formula: see text]), and blood flow ([Formula: see text]) indices. DCM patients additionally underwent a standard neurological clinical assessment. Regression analysis assessed associations between perfusion parameters, clinical outcome measures, and remote spinal cord atrophy. Twenty-nine DCM patients and 30 healthy controls were enrolled in the study. At the level of stenosis, 11 patients showed focal radiological evidence of cervical myelopathy. Above the stenosis level, cord atrophy was observed in the WM (- 9.3%; p = 0.005) and GM (- 6.3%; p = 0.008) in patients compared to healthy controls. Blood velocity (BV) and blood flow (BF) indices were decreased in the ventral horns of the GM (BV: - 20.1%, p = 0.0009; BF: - 28.2%, p = 0.0008), in the ventral funiculi (BV: - 18.2%, p = 0.01; BF: - 21.5%, p = 0.04) and lateral funiculi (BV: - 8.5%, p = 0.03; BF: - 16.5%, p = 0.03) of the WM, across C1-C3 levels. A decrease in microvascular volume fraction was associated with GM atrophy (R = 0.46, p = 0.02). This study demonstrates tissue-specific cervical perfusion impairment rostral to the compression site in DCM patients. IVIM indices are sensitive to remote perfusion changes in the cervical cord in DCM and may serve as neuroimaging biomarkers of hemodynamic impairment in future studies. The association between perfusion impairment and cervical cord atrophy indicates that changes in hemodynamics caused by compression may contribute to the neurodegenerative processes in DCM.

Indexed as

Cervical CordMusculoskeletal DiseasesSpinal Cord CompressionSpinal Cord DiseasesAtrophyCervical VertebraeConstriction, PathologicHumansMagnetic Resonance ImagingPerfusion

Identifiers

PMID38114733
PMCPMC10730822
OpenAlexW4389955022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.